Ketamine: Clinical Studies in Treatment-Resistant Depressive Disorders-Reference-Cited by-同舟云学术

Ketamine: Clinical Studies in Treatment-Resistant Depressive Disorders

Published:2016 Issue: Volume: Page:31-42
ISSN:
Container-title:Ketamine for Treatment-Resistant Depression
language:
Short-container-title:

Author:

Blier Pierre,Blier Jean

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-42925-0_3

Reference37 articles.

1. aan het Rot M, Collins KA, Murrough JW et al (2010) Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiat 67:139–145

2. Anisman H (2009) Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorders. J Psychiat Neurosci 34:4–20

3. Berman RM, Cappiello A, Anand A et al (2000) Antidepressant effect of ketamine in depressed patients. Biol Psychiat 47:35–354

4. Blier P (2013) Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder. Biol Psychiat 74:238–239

5. Blier P, Zigman D, Blier J (2012) On the safety and benefits of repeated intravenous injections of ketamine for depression. Biol Psychiat 72:e11–e12

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twenty-Four-Hour Heart Rate Is a Trait but Not State Marker for Depression in a Pilot Randomized Controlled Trial With a Single Infusion of Ketamine;Frontiers in Psychiatry;2021-07-29

2. The influence of ketamine on drug discovery in depression;Drug Discovery Today;2019-10

3. Neuroimmunopharmacology at the Interface of Inflammation and Pharmacology Relevant to Depression;Inflammation and Immunity in Depression;2018